Clinical implications of cytomegalovirus in glioblastoma progression and therapy
Abstract Glioblastoma (GBM) is one of the deadliest brain cancers with a median survival of only 15 months. This poor prognosis has prompted exploration of novel therapeutic targets for GBM patients. Human cytomegalovirus (HCMV) has been implicated in GBM; however, its impact remains poorly defined,...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Portfolio
2024-09-01
|
| Collection: | npj Precision Oncology |
| Accès en ligne: | https://doi.org/10.1038/s41698-024-00709-4 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|